We are live on ! Find out more
PDLI

PDL BioPharma, Inc.
PDLI

Delisted

PDLI was delisted on the 30th of December, 2020.

Back to rankings

224 hedge funds and large institutions have $1.17B invested in PDL BioPharma, Inc. in 2013 Q4 according to their latest regulatory filings, with 39 funds opening new positions, 93 increasing their positions, 59 reducing their positions, and 27 closing their positions.

New
Increased
Maintained
Reduced
Closed

265% more call options, than puts

Call options by funds: $12.4M | Put options by funds: $3.4M

58% more repeat investments, than reductions

Existing positions increased: 93 | Existing positions reduced: 59

44% more first-time investments, than exits

New positions opened: 39 | Existing positions closed: 27

9% more capital invested

Capital invested by funds: $1.08B → $1.17B (+$93.2M)

6% more funds holding

Funds holding: 212 → 224 (+12)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

Holders
224
Holders Change
+12
Holders Change %
+5.66%
% of All Funds
6.5%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
39
Increased
93
Reduced
59
Closed
27
Calls
$12.4M
Puts
$3.4M
Net Calls
+$9.02M
Net Calls Change
-$624K

Top Buyers

Rank Fund Capital Flow
1
NI
Numeric Investors
Massachusetts
+$14.5M
2
Schroder Investment Management Group
Schroder Investment Management Group
United Kingdom
+$7.19M
3
Susquehanna International Group
Susquehanna International Group
Pennsylvania
+$6.66M
4
Bank of Montreal
Bank of Montreal
Ontario, Canada
+$5.78M
5
Invesco
Invesco
Georgia
+$5.39M

Top Sellers

Rank Fund Capital Flow
1
HSA
Hussman Strategic Advisors
Maryland
-$9.53M
2
GC
Guggenheim Capital
Illinois
-$8.24M
3
Two Sigma Investments
Two Sigma Investments
New York
-$7.8M
4
Principal Financial Group
Principal Financial Group
Iowa
-$6.62M
5
Two Sigma Advisers
Two Sigma Advisers
New York
-$5.4M
Name Holding Trade Value Shares
Change 		Change in
Stake
FQ
76
First Quadrant
California
$2.14M – – –
SONJCPFA
77
State of New Jersey Common Pension Fund A
New Jersey
$2.07M – – –
Fiera Capital (Canada)
78
Fiera Capital (Canada)
Quebec, Canada
$1.95M +$450K +53,400 +30%
KBC Group
79
KBC Group
Belgium
$1.83M +$1.83M +216,576 New
SFM
80
Systematic Financial Management
New Jersey
$1.82M +$310K +36,760 +20%
BC
81
Burney Company
Virginia
$1.8M +$476K +56,463 +36%
CIBC World Market
82
CIBC World Market
Ontario, Canada
$1.79M +$382K +45,349 +27%
ACI
83
AMP Capital Investors
Australia
$1.74M +$305K +36,149 +21%
State Board of Administration of Florida Retirement System
84
State Board of Administration of Florida Retirement System
Florida
$1.71M – – –
BG
85
BlackRock Group
United Kingdom
$1.7M -$168K -19,884 -9%
DC
86
Deere & Company
Illinois
$1.65M +$1.43M +169,350 +654%
ZCM
87
Zebra Capital Management
Connecticut
$1.63M +$341K +40,448 +27%
BNP Paribas Financial Markets
88
BNP Paribas Financial Markets
France
$1.62M +$29.9K +3,544 +2%
SCP
89
Seizert Capital Partners
Michigan
$1.41M +$1.4M +166,450 New
AL
90
Airain Ltd
Guernsey
$1.39M +$1.39M +164,512 New
GC
91
Globeflex Capital
California
$1.33M -$2.53K -300 -0.2%
AI
92
Atria Investments
North Carolina
$1.26M +$403K +47,808 +47%
RhumbLine Advisers
93
RhumbLine Advisers
Massachusetts
$1.24M -$3.54K -420 -0.3%
LPL Financial
94
LPL Financial
California
$1.2M +$222K +26,288 +23%
PAM
95
Paradigm Asset Management
New York
$1.19M +$124K +14,700 +12%
DCM
96
Dupont Capital Management
Delaware
$1.17M -$1.74M -206,857 -60%
AIG
97
American International Group
New York
$1.16M +$269K +31,921 +30%
SO
98
STRS Ohio
Ohio
$1.09M -$190K -22,500 -15%
HighTower Advisors
99
HighTower Advisors
Illinois
$1.09M +$364K +43,170 +50%
Connor, Clark & Lunn Investment Management (CC&L)
100
Connor, Clark & Lunn Investment Management (CC&L)
British Columbia, Canada
$1.01M -$954K -113,261 -50%
2 3
4
5 6

PDLI Hedge Fund Activity: Q4 2013 in Review

224 of the 3,446 institutional investors tracked by Wall St. Rank reported a position in PDL BioPharma, Inc. (PDLI) for Q4 2013, worth a combined $1.17B — up 8.7% from $1.08B a quarter earlier.

Buyers outnumbered sellers: 39 funds opened new PDLI positions and 27 closed out — a net gain of 12 holders — while 93 added to existing stakes and 59 trimmed.

The largest buyer was Numeric Investors, adding an estimated $14.5M. The largest seller was Hussman Strategic Advisors, cutting an estimated $9.53M.

  • 224 institutional investors held PDL BioPharma, Inc. (PDLI) as of Q4 2013, up from 212 in Q3 2013.
  • Funds reported $1.17B of PDL BioPharma, Inc. stock for Q4 2013, up 8.7% quarter-over-quarter.
  • 39 funds opened new PDL BioPharma, Inc. positions in Q4 2013 and 27 closed out, a net change of +12 holders.
  • The largest PDL BioPharma, Inc. buyer in Q4 2013 was Numeric Investors, an estimated $14.5M added.
  • The largest PDL BioPharma, Inc. seller in Q4 2013 was Hussman Strategic Advisors, an estimated $9.53M sold.

Based on aggregated 13F filings for Q4 2013.